Skip to content

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

News

Read the latest news about our company.
To learn more about our research, visit our publications page.

See our publications

Year
Media Type
Search

October 23, 2024 | Press Release

Interius BioTherapeutics Doses First Patient with in vivo Chimeric Antigen Receptor (CAR) Gene Therapy for B-cell Malignancies

July 9, 2024 | Press Release

Interius BioTherapeutics Receives HREC Approval and CTN Clearance from the TGA to Commence a Phase 1 Clinical Trial for Its First-in-Class In Vivo CAR Therapeutic for B Cell Malignancies

June 21, 2023 | Press Release

Interius BioTherapeutics Highlights Strong Preclinical Data Supporting In Vivo Chimeric Antigen Receptor (CAR) Vector Evaluation in Clinic

May 9, 2023 | Press Release

Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies

April 27, 2023 | Press Release

Interius BioTherapeutics Hosts Immersive, Hands-on Event to Ignite Students’ Passion for Science

December 9, 2021 | Press Release

Interius Bio Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform

12

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

Science

Platform
Pipeline
INT2104
INT2106
Publications
Clinical Trials

Company

About Us
Leadership
Board of Directors
Careers
Contact
News

Copyright © 2024 Interius BioTherapeutics, Inc. All Rights Reserved.
Interius^® is a registered trademark of Interius BioTherapeutics, Inc.

Accessibility
Cookies Notice
Privacy Notice
Terms of Use